302 related articles for article (PubMed ID: 2209697)
41. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
Moreno J; Adorini L; Hämmerling GJ
J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
[TBL] [Abstract][Full Text] [Related]
42. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
Mourad W; Scholl P; Diaz A; Geha R; Chatila T
J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
[TBL] [Abstract][Full Text] [Related]
43. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.
Fleischer B; Gerardy-Schahn R; Metzroth B; Carrel S; Gerlach D; Köhler W
J Immunol; 1991 Jan; 146(1):11-7. PubMed ID: 1670601
[TBL] [Abstract][Full Text] [Related]
44. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
[TBL] [Abstract][Full Text] [Related]
45. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
Damle NK; Leytze G; Klussman K; Ledbetter JA
Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
[TBL] [Abstract][Full Text] [Related]
46. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
Altomonte M; Pucillo C; Damante G; Maio M
J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
[TBL] [Abstract][Full Text] [Related]
47. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
Pontzer CH; Russell JK; Johnson HM
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
[TBL] [Abstract][Full Text] [Related]
48. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.
Karp DR; Jenkins RN; Long EO
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9657-61. PubMed ID: 1409679
[TBL] [Abstract][Full Text] [Related]
49. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
[TBL] [Abstract][Full Text] [Related]
50. Transcriptional and translational control of TNF-alpha gene expression in human monocytes by major histocompatibility complex class II ligands.
Espel E; Garcia-Sanz JA; Aubert V; Menoud V; Sperisen P; Fernández N; Spertini F
Eur J Immunol; 1996 Oct; 26(10):2417-24. PubMed ID: 8898955
[TBL] [Abstract][Full Text] [Related]
51. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes.
See RH; Krystal G; Chow AW
Can J Microbiol; 1992 Sep; 38(9):937-44. PubMed ID: 1281444
[TBL] [Abstract][Full Text] [Related]
52. A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathway.
Haregewoin A; Edwin C; Hom RC; Finberg R
Immunol Invest; 1994 Nov; 23(6-7):413-20. PubMed ID: 7851959
[TBL] [Abstract][Full Text] [Related]
53. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.
Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662
[TBL] [Abstract][Full Text] [Related]
54. Porcine MHC classical class I genes are coordinately expressed in superantigen-activated mononuclear cells.
Kametani Y; Ohshima S; Kita YF; Shimada S; Kamiguchi H; Shiina T; Inoko H; Kulski JK; Ando A
Vet Immunol Immunopathol; 2012 Aug; 148(3-4):252-9. PubMed ID: 22640570
[TBL] [Abstract][Full Text] [Related]
55. Activator protein-1 (AP-1) is stimulated by microbial superantigens in human monocytic cells.
Trede NS; Chatila T; Geha RS
Eur J Immunol; 1993 Sep; 23(9):2129-35. PubMed ID: 8370396
[TBL] [Abstract][Full Text] [Related]
56. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules.
Thibodeau J; Labrecque N; Denis F; Huber BT; Sékaly RP
J Exp Med; 1994 Mar; 179(3):1029-34. PubMed ID: 8113671
[TBL] [Abstract][Full Text] [Related]
57. Bacterial superantigen specificities of mouse T cell receptor V beta 20.
Bravo de Alba Y; Cazenave PA; Marche PN
Eur J Immunol; 1995 Dec; 25(12):3425-30. PubMed ID: 8566033
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A.
Masewicz S; Ledbetter JA; Martin P; Mickelson E; Hansen JA; Odum N
Hum Immunol; 1993 Mar; 36(3):142-8. PubMed ID: 8320132
[TBL] [Abstract][Full Text] [Related]
59. A phenotypically dominant regulatory mechanism suppresses major histocompatibility complex class II gene expression in a murine plasmacytoma.
Venkitaraman AR; Culbert EJ; Feldmann M
Eur J Immunol; 1987 Oct; 17(10):1441-6. PubMed ID: 3500056
[TBL] [Abstract][Full Text] [Related]
60. Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1.
Aubert V; Schneeberger D; Sauty A; Winter J; Sperisen P; Aubert JD; Spertini F
Infect Immun; 2000 Jan; 68(1):120-4. PubMed ID: 10603377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]